Werner Meier
Chief Tech/Sci/R&D Officer at Revitope Oncology, Inc.
Profile
Werner Meier is associated with Revitope Oncology, Inc. as the Chief Scientific Officer & Director and with Revitope Ltd.
as a Director since 2019.
Werner Meier active positions
| Companies | Position | Start |
|---|---|---|
Revitope Oncology, Inc.
 Revitope Oncology, Inc. Hospital/Nursing ManagementHealth Services Revitope Oncology, Inc. develops a programmable antibody circuit pipeline in particular redirecting T cells to tumors. The company was founded by Andrew Allen and Mark Cobbold and is headquartered in Cambridge, MA. | Chief Tech/Sci/R&D Officer | - |
Revitope Ltd.
 Revitope Ltd. Miscellaneous Commercial ServicesCommercial Services Founded in 2014, Revitope Ltd. is a British biotechnology company that operates as a developer of cancer therapies. The company is based in Hertfordshire, UK and is part of Revitope Oncology, Inc. | Director/Board Member | 01/01/2019 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Revitope Oncology, Inc.
Revitope Oncology, Inc. Hospital/Nursing ManagementHealth Services Revitope Oncology, Inc. develops a programmable antibody circuit pipeline in particular redirecting T cells to tumors. The company was founded by Andrew Allen and Mark Cobbold and is headquartered in Cambridge, MA. | Health Services |
Revitope Ltd.
Revitope Ltd. Miscellaneous Commercial ServicesCommercial Services Founded in 2014, Revitope Ltd. is a British biotechnology company that operates as a developer of cancer therapies. The company is based in Hertfordshire, UK and is part of Revitope Oncology, Inc. | Commercial Services |
- Stock Market
- Insiders
- Werner Meier
